Please use this identifier to cite or link to this item:
https://doi.org/10.18632/oncotarget.10451
DC Field | Value | |
---|---|---|
dc.title | Gelsolin-Cu/ZnSOD interaction alters intracellular reactive oxygen species levels to promote cancer cell invasion | |
dc.contributor.author | Tochhawng, L | |
dc.contributor.author | Deng, S | |
dc.contributor.author | Pugalenthi, G | |
dc.contributor.author | Kumar, A.P | |
dc.contributor.author | Lim, K.H | |
dc.contributor.author | Yang, H | |
dc.contributor.author | Hooi, S.C | |
dc.contributor.author | Goh, Y.C | |
dc.contributor.author | Maciver, S.K | |
dc.contributor.author | Pervaiz, S | |
dc.contributor.author | Yap, C.T | |
dc.date.accessioned | 2020-09-09T01:29:55Z | |
dc.date.available | 2020-09-09T01:29:55Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Tochhawng, L, Deng, S, Pugalenthi, G, Kumar, A.P, Lim, K.H, Yang, H, Hooi, S.C, Goh, Y.C, Maciver, S.K, Pervaiz, S, Yap, C.T (2016). Gelsolin-Cu/ZnSOD interaction alters intracellular reactive oxygen species levels to promote cancer cell invasion. Oncotarget 7 (33) : 52832-52848. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.10451 | |
dc.identifier.issn | 19492553 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/174944 | |
dc.description.abstract | The actin-binding protein, gelsolin, is a well known regulator of cancer cell invasion. However, the mechanisms by which gelsolin promotes invasion are not well established. As reactive oxygen species (ROS) have been shown to promote cancer cell invasion, we investigated on the hypothesis that gelsolin-induced changes in ROS levels may mediate the invasive capacity of colon cancer cells. Herein, we show that increased gelsolin enhances the invasive capacity of colon cancer cells, and this is mediated via gelsolin's effects in elevating intracellular superoxide (O2.-) levels. We also provide evidence for a novel physical interaction between gelsolin and Cu/ZnSOD, that inhibits the enzymatic activity of Cu/ZnSOD, thereby resulting in a sustained elevation of intracellular O2.-. Using microarray data of human colorectal cancer tissues from Gene Omnibus, we found that gelsolin gene expression positively correlates with urokinase plasminogen activator (uPA), an important matrix-degrading protease invovled in cancer invasion. Consistent with the in vivo evidence, we show that increased levels of O2.- induced by gelsolin overexpression triggers the secretion of uPA. We further observed reduction in invasion and intracellular O2.- levels in colon cancer cells, as a consequence of gelsolin knockdown using two different siRNAs. In these cells, concurrent repression of Cu/ ZnSOD restored intracellular O2.- levels and rescued invasive capacity. Our study therefore identified gelsolin as a novel regulator of intracellular O2.- in cancer cells via interacting with Cu/ZnSOD and inhibiting its enzymatic activity. Taken together, these findings provide insight into a novel function of gelsolin in promoting tumor invasion by directly impacting the cellular redox milieu. | |
dc.publisher | Impact Journals LLC | |
dc.source | Unpaywall 20200831 | |
dc.subject | copper zinc superoxide dismutase | |
dc.subject | gelsolin | |
dc.subject | proteinase | |
dc.subject | reactive oxygen metabolite | |
dc.subject | urokinase | |
dc.subject | copper zinc superoxide dismutase | |
dc.subject | gelsolin | |
dc.subject | protein binding | |
dc.subject | reactive oxygen metabolite | |
dc.subject | urokinase | |
dc.subject | Article | |
dc.subject | bioinformatics | |
dc.subject | cancer tissue | |
dc.subject | cell invasion | |
dc.subject | controlled study | |
dc.subject | enzyme activity | |
dc.subject | enzyme degradation | |
dc.subject | enzyme release | |
dc.subject | gelsolin gene | |
dc.subject | gene expression regulation | |
dc.subject | gene overexpression | |
dc.subject | HCT116 cell line | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | human tissue | |
dc.subject | in vitro study | |
dc.subject | microarray analysis | |
dc.subject | protein protein interaction | |
dc.subject | tumor invasion | |
dc.subject | upregulation | |
dc.subject | Caco-2 cell line | |
dc.subject | chemistry | |
dc.subject | colon tumor | |
dc.subject | gene expression profiling | |
dc.subject | genetics | |
dc.subject | HCT 116 cell line | |
dc.subject | HeLa cell line | |
dc.subject | Hep-G2 cell line | |
dc.subject | metabolism | |
dc.subject | molecular model | |
dc.subject | pathology | |
dc.subject | procedures | |
dc.subject | protein domain | |
dc.subject | RNA interference | |
dc.subject | tumor cell line | |
dc.subject | tumor invasion | |
dc.subject | Caco-2 Cells | |
dc.subject | Cell Line, Tumor | |
dc.subject | Colonic Neoplasms | |
dc.subject | Gelsolin | |
dc.subject | Gene Expression Profiling | |
dc.subject | Gene Expression Regulation, Neoplastic | |
dc.subject | HCT116 Cells | |
dc.subject | HeLa Cells | |
dc.subject | Hep G2 Cells | |
dc.subject | Humans | |
dc.subject | Models, Molecular | |
dc.subject | Neoplasm Invasiveness | |
dc.subject | Protein Binding | |
dc.subject | Protein Domains | |
dc.subject | Reactive Oxygen Species | |
dc.subject | RNA Interference | |
dc.subject | Superoxide Dismutase-1 | |
dc.subject | Urokinase-Type Plasminogen Activator | |
dc.type | Article | |
dc.contributor.department | BIOCHEMISTRY | |
dc.contributor.department | PHYSIOLOGY | |
dc.contributor.department | CANCER SCIENCE INSTITUTE OF SINGAPORE | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.description.doi | 10.18632/oncotarget.10451 | |
dc.description.sourcetitle | Oncotarget | |
dc.description.volume | 7 | |
dc.description.issue | 33 | |
dc.description.page | 52832-52848 | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_18632_oncotarget_10451.pdf | 3.59 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.